Fluorescein-conjugated hyaluronic acid enables visualization of retained ophthalmic viscosurgical device in anterior chamber.

Published in: Journal of cataract and refractive surgery (2024)

Use of OVD composed of fluorescein-conjugated HA is a feasible method to enable conditional visualization of OVD intraoperatively without nonspecific staining of ocular structures. Further development of this technology may enable accelerated OVD removal in ocular surgery or decreased OVD retention following surgery.

Keyphrases

hyaluronic acid
minimally invasive
coronary artery bypass
photodynamic therapy
surgical site infection
optic nerve
percutaneous coronary intervention
acute coronary syndrome
optical coherence tomography